Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ MalignanciesLucila Nassif Kerbauy, Katayoun Rezvani|Clinical Cancer Research|2021Cited by 149